Treatment of ARDS With Sivelestat Sodium (TOAWSS)

  • STATUS
    Recruiting
  • End date
    Jul 30, 2024
  • participants needed
    324
  • sponsor
    Sichuan Provincial People's Hospital
Updated on 29 April 2022
absolute neutrophil count
acute respiratory distress
FIO2
pao2

Summary

Neutrophil elastase (NE) released by neutrophils play an important role in inflammatory cascade and lung tissue injury of ARDS.Inhibition of NE is expected to prevent the pathophysiological process of ARDS and alleviate lung injury. Siverestat sodium is a specific inhibitor of NE, which has been proved by basic and observational clinical studies to be effective in alleviating lung injury of ARDS, but there is a lack of prospective multi-center randomized controlled clinical trials.Therefore, this study was intended to evaluate the efficacy of sivelestat sodium in the treatment of ARDS patients with SIRS in a multicenter randomized controlled clinical trial

Details
Condition Acute Respiratory Distress Syndrome
Treatment Saline, Sivelestat sodium
Clinical Study IdentifierNCT04909697
SponsorSichuan Provincial People's Hospital
Last Modified on29 April 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Males and females > 18 years old and <75 years old (non-pregnant, non-lactating females)
Patients fulfilled the Berlin diagnostic criteria of acute respiratory distress syndrome, with a arterial oxygen partial pressure (PaO2) to fraction of inspired oxygen (FiO2) between 150 mmHg and 300 mmHg
Signed written informed consent has been obtained

Exclusion Criteria

History of chronic respiratory disease
Single cardiogenic pulmonary edema
Apach2 score ≥21 points
Complicated with end-stage disease, or poor prognosis judged by the clinical doctor in charge
ARDS course>3 days
Agranulocytosis or receiving immunosuppressive agents or high doses of corticosteroids (methylprednisolone>40mg/day)
Pregnancy or breastfeeding
Participated in this study
Do not agree to participate in this experiment
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note